Ming-Hwa Liang, Ph.D. is Secretary, Strategic Technology Development Officer of the company. Mr. Liang had been the director of research and development at Biowell Technology Inc. Mr. Liang received a B.S. in Bio-Agriculture from Colorado State University in 1989, a M.S. in Horticulture from the University of Missouri at Columbia in 1991, his Ph.D. in Plant Science from the University of Missouri at Columbia in 1997 and his LL.M. in Intellectual Property Law from Shih Hsin University, Taiwan in 2004.
As the Secretary and Strategic Technology Development Officer of Applied Dna Sciences Inc, the total compensation of Ming Liang at Applied Dna Sciences Inc is $460,540. There are 2 executives at Applied Dna Sciences Inc getting paid more, with James Hayward having the highest compensation of $1,392,560.
Ming Liang is 51, he's been the Secretary and Strategic Technology Development Officer of Applied Dna Sciences Inc since 2005. There are 9 older and 5 younger executives at Applied Dna Sciences Inc. The oldest executive at Applied Dna Sciences Inc is Robert Catell, 80, who is the Director.
Ming's mailing address filed with the SEC is 50, Health Sciences Drive, Stony Brook University, Suffolk, New York, 11794, United States.
Over the last 21 years, insiders at Applied Dna Sciences Inc have traded over $13,655,198 worth of Applied Dna Sciences Inc stock and bought 12,115,698 units worth $17,246,871 . The most active insiders traders include Management Inc Rhl, Lawrence Lee, and Dwyer Management Inc O. On average, Applied Dna Sciences Inc executives and independent directors trade stock every 59 days with the average trade being worth of $312,035. The most recent stock trade was executed by Scott L Anchin on 10 March 2021, trading 13,049 units of APDN stock currently worth $110,003.
we keep life real and safe by providing botanical-dna based security and authentication solutions and services that protect assets, products, brands, supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.
Applied Dna Sciences Inc executives and other stock owners filed with the SEC include: